Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16892069rdf:typepubmed:Citationlld:pubmed
pubmed-article:16892069lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:16892069lifeskim:mentionsumls-concept:C0927232lld:lifeskim
pubmed-article:16892069lifeskim:mentionsumls-concept:C0014072lld:lifeskim
pubmed-article:16892069lifeskim:mentionsumls-concept:C0040648lld:lifeskim
pubmed-article:16892069lifeskim:mentionsumls-concept:C0079904lld:lifeskim
pubmed-article:16892069lifeskim:mentionsumls-concept:C2243187lld:lifeskim
pubmed-article:16892069pubmed:issue9lld:pubmed
pubmed-article:16892069pubmed:dateCreated2006-8-22lld:pubmed
pubmed-article:16892069pubmed:abstractTextActivation of transcription factor NF-kappaB in the central nervous system (CNS) has been linked to autoimmune demyelinating disease; however, it remains unclear whether its function is protective or pathogenic. Here we show that CNS-restricted ablation of 'upstream' NF-kappaB activators NEMO or IKK2 but not IKK1 ameliorated disease pathology in a mouse model of multiple sclerosis, suggesting that 'canonical' NF-kappaB activation in cells of the CNS has a mainly pathogenic function in autoimmune demyelinating disease. NF-kappaB inhibition prevented the expression of proinflammatory cytokines, chemokines and the adhesion molecule VCAM-1 from CNS-resident cells. Thus, NF-kappaB-dependent gene expression in non-microglial cells of the CNS provides a permissive proinflammatory milieu that is critical for CNS inflammation and tissue damage in autoimmune demyelinating disease.lld:pubmed
pubmed-article:16892069pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16892069pubmed:languageenglld:pubmed
pubmed-article:16892069pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16892069pubmed:citationSubsetIMlld:pubmed
pubmed-article:16892069pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16892069pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16892069pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16892069pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16892069pubmed:statusMEDLINElld:pubmed
pubmed-article:16892069pubmed:monthSeplld:pubmed
pubmed-article:16892069pubmed:issn1529-2908lld:pubmed
pubmed-article:16892069pubmed:authorpubmed-author:LassmannHansHlld:pubmed
pubmed-article:16892069pubmed:authorpubmed-author:PasparakisMan...lld:pubmed
pubmed-article:16892069pubmed:authorpubmed-author:Schmidt-Suppr...lld:pubmed
pubmed-article:16892069pubmed:authorpubmed-author:van LooGeertGlld:pubmed
pubmed-article:16892069pubmed:authorpubmed-author:HuthMarionMlld:pubmed
pubmed-article:16892069pubmed:authorpubmed-author:De...lld:pubmed
pubmed-article:16892069pubmed:authorpubmed-author:MildnerAlexan...lld:pubmed
pubmed-article:16892069pubmed:authorpubmed-author:SchmidtHaukeHlld:pubmed
pubmed-article:16892069pubmed:authorpubmed-author:PrinzMarco...lld:pubmed
pubmed-article:16892069pubmed:issnTypePrintlld:pubmed
pubmed-article:16892069pubmed:volume7lld:pubmed
pubmed-article:16892069pubmed:ownerNLMlld:pubmed
pubmed-article:16892069pubmed:authorsCompleteYlld:pubmed
pubmed-article:16892069pubmed:pagination954-61lld:pubmed
pubmed-article:16892069pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:16892069pubmed:meshHeadingpubmed-meshheading:16892069...lld:pubmed
pubmed-article:16892069pubmed:meshHeadingpubmed-meshheading:16892069...lld:pubmed
pubmed-article:16892069pubmed:meshHeadingpubmed-meshheading:16892069...lld:pubmed
pubmed-article:16892069pubmed:meshHeadingpubmed-meshheading:16892069...lld:pubmed
pubmed-article:16892069pubmed:meshHeadingpubmed-meshheading:16892069...lld:pubmed
pubmed-article:16892069pubmed:meshHeadingpubmed-meshheading:16892069...lld:pubmed
pubmed-article:16892069pubmed:meshHeadingpubmed-meshheading:16892069...lld:pubmed
pubmed-article:16892069pubmed:meshHeadingpubmed-meshheading:16892069...lld:pubmed
pubmed-article:16892069pubmed:meshHeadingpubmed-meshheading:16892069...lld:pubmed
pubmed-article:16892069pubmed:meshHeadingpubmed-meshheading:16892069...lld:pubmed
pubmed-article:16892069pubmed:meshHeadingpubmed-meshheading:16892069...lld:pubmed
pubmed-article:16892069pubmed:meshHeadingpubmed-meshheading:16892069...lld:pubmed
pubmed-article:16892069pubmed:meshHeadingpubmed-meshheading:16892069...lld:pubmed
pubmed-article:16892069pubmed:meshHeadingpubmed-meshheading:16892069...lld:pubmed
pubmed-article:16892069pubmed:meshHeadingpubmed-meshheading:16892069...lld:pubmed
pubmed-article:16892069pubmed:year2006lld:pubmed
pubmed-article:16892069pubmed:articleTitleInhibition of transcription factor NF-kappaB in the central nervous system ameliorates autoimmune encephalomyelitis in mice.lld:pubmed
pubmed-article:16892069pubmed:affiliationEuropean Molecular Biology Laboratory Mouse Biology Unit, I-00016 Monterotondo, Italy.lld:pubmed
pubmed-article:16892069pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16892069pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:16150entrezgene:pubmedpubmed-article:16892069lld:entrezgene
entrez-gene:16151entrezgene:pubmedpubmed-article:16892069lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16892069lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16892069lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16892069lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16892069lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16892069lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16892069lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16892069lld:pubmed